3 reports

  • PARTNERSHIP - DEAL REPORTS
  • PARTNERSHIP - DEAL REPORTS

Acambis also has the only vaccine in development against Clostridium difficile bacteria, a leading cause of hospital-acquired infections.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Vaccine
  • Vivalis SA
  • PARTNERSHIP - DEAL REPORTS
  • PARTNERSHIP - DEAL REPORTS

Acambis also has the only vaccine in development against Clostridium difficile bacteria, a leading cause of hospital-acquired infections.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Vaccine
  • Vivalis SA
  • PARTNERSHIP - DEAL REPORTS

It is engaged in operation of Kitasato University, graduate schools, research laboratories, hospitals, nursing schools, research center for biologicals, and a college for health and hygienic sciences.

  • Cell Therapy
  • Healthcare
  • Pharmaceutical
  • Vaccine
  • Vivalis SA